Hermann‐Josef Gertz

Author

Hermann‐Josef Gertz

Also Known As

Elisabeth Roggenhofer, H Gertz, H J Gertz, H. -J. Gertz, H. Gertz, H. J Gertz, H. J. Gertz, H.-J. Gertz, H.-J. Gertz, H.J. Gertz

143

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Leipzig University University Hospital Leipzig Charité - Universitätsmedizin Berlin Central Institute of Mental Health Heidelberg University

About

Hermann‐Josef Gertz is an author at Leipzig University specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	32	2K
2	Social Sciences	8	8	474
3	Health Sciences	3	3	156
4	Engineering	1	1	38
5	Nursing	1	1	119

Hermann‐Josef Gertz

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study Henryk Barthel, Hermann‐Josef Gertz, S. Dresel, The Lancet Neurology Neurodegenerative DiseasesDiagnostic StudyAlzheimer's DiseaseCerebral Amyloid-β PetNeurochemical Biomarkers	2011	574
Early neurone loss in Alzheimer’s disease: cortical or subcortical? Thomas Arendt, Martina K. Brückner, Markus Morawski, Acta Neuropathologica Communications	2015	200
PET Quantification of <sup>18</sup>F-Florbetaben Binding to β-Amyloid Deposits in Human Brains Georg Becker, Masanori Ichise, Henryk Barthel, Journal of Nuclear Medicine	2013	127
Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study Henrike Wolf, Gustav Martin Ecke, Simone Bettin, International Journal of Geriatric Psychiatry	2000	124
CORDIAL Alexander Kurz, Angelika Thöne-Otto, Barbara Cramer, Alzheimer Disease & Associated Disorders NursingAlzheimer's DiseasePsychiatryGeriatricsMedicine	2011	119
Serum lipids and hippocampal volume: The link to Alzheimer's disease? Henrike Wolf, Anke Hensel, Thomas Arendt, Annals of Neurology	2004	108
Structural correlates of mild cognitive impairment Henrike Wolf, Anke Hensel, Frithjof Kruggel, Neurobiology of Aging Neuropsychological FunctioningNeuropsychologyAlzheimer's DiseaseCognitive NeuroscienceDementia	2003	106
Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing Piotr Lewczuk, Johannes Kornhuber, Eugeen Vanmechelen, Experimental Neurology Early DiagnosisNeurodegenerative DiseasesAlzheimer's DiseaseBiomarkersNeurochemical Biomarkers	2009	100
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls Henryk Barthel, Julia Luthardt, Georg Becker, European Journal of Nuclear Medicine and Molecular Imaging Neurodegenerative DiseasesAlzheimer's DiseaseMechanism Phase 0Brain β-Amyloid BurdenBiomarkers	2011	96
Anosognosia in Alzheimer’s disease: The role of impairment levels in assessment of insight across domains Hanna Leicht, Martin Berwig, Hermann‐Josef Gertz Journal of the International Neuropsychological Society	2010	91

Page 1